3,908 research outputs found

    Spectral and total radiation properties of turbulent carbon monoxide/air diffusion flames

    Full text link
    Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/76724/1/AIAA-1986-294-399.pd

    Direct esterification of poly (ethylene glycol) with amino acid hydrochlorides

    Get PDF
    Diesters of poly (ethylene glycol) with various a amino acid hydrochlorides were synthesized using dicyclohexyl carbodiimide as coupling agent. The use of hydrochloride as amino protecting group in dicyclohexyl carbodiimide mediated condensation reactions of amino acids was demonstrated for the first time

    Transition Metal Carbohydrazide Nitrates: Burn-rate Modifiers for Propellants

    Get PDF
    This paper discusses the synthesis and characterisation of cobalt (Co), nickel (Ni) andcopper (Cu) carbohydrazide nitrates. In differential scanning calorimetry (DSC), the complexesexhibited exothermic decomposition indicating their energetic nature. The commencement ofdecomposition was observed at 220 °C for Ni complex, and at 160 °C for Co complex whereasthat of Cu complex occurred at 75 °C. In view of the better thermal stability, Ni and Co complexeswere selected for further study. The activation energy of decomposition of Ni and Co complexeswere found to be 47 kcal/mol and 60 kcal/mol respectively. Impact and friction sensitivity testresults revealed relatively lower vulnerability of carbohydrazide cobalt nitrate. Its incorporationin an ammonium perchlorate (AP)-based composite propellant led to 9-19 per cent enhancementwhereas that of carbohydrazide nickel nitrate resulted in 28-74 per cent enhancement in burningrates in the pressure range 1.9 MPa to 8.8 MPa. Exothermic decomposition of the coordinationcomplexes on propellant surface and involvement of metal at molecular level formed ondecomposition of the complexes in combustion environment of composite propellant may beattributed to the catalytic effect of this class of compounds on the lines of reported literature

    Hepatitis B testing and treatment in HIV patients in The Gambia - compliance with international guidelines and clinical outcomes

    Get PDF
    Background Compliance with WHO guidelines on HBV screening and treatment in HIV-coinfected patients is often challenging in resource limited countries and has been poorly assessed in sub-Saharan Africa. Methods Between 2015 and 2016, we assessed physician’s compliance with WHO guidelines on HIV-HBV coinfection in the largest HIV clinic in The Gambia, and the hepatic outcomes in HIV-HBV coinfected patients as compared to randomly selected HIV-monoinfected controls. Results 870 HIV-infected patients regularly seen in this clinic agreed to participate in our study. Only 187 (21.5%, 95% CI 18.8–24.3) had previously been screened for HBsAg, 23 (12.3%, 95% CI 8.0–17.9) were positive of whom none had liver assessment and only 6 (26.1%) had received Tenofovir. Our HBV testing intervention was accepted by all participants and found 94/870 (10.8%, 95% CI 8.8–13.1) positive, 78 of whom underwent full liver assessment along with 40 HBsAg-negative controls. At the time of liver assessment, 61/78 (78.2%) HIV-HBV coinfected patients received ART with 7 (11.5%) on Tenofovir and 54 (88.5%) on Lamivudine alone. HIV-HBV coinfected patients had higher APRI score compared to controls (0.58 vs 0.42, p = 0.002). HBV DNA was detectable in 52/53 (98.1%) coinfected patients with 14/53 (26.4%) having HBV DNA >20,000 IU/L. 10/12 (83.3%) had at least one detectable 3TC-associated HBV resistance, which tended to be associated with increase in liver fibrosis after adjusting for age and sex (p = 0.05). Conclusions Compliance with HBV testing and treatment guidelines is poor in this Gambian HIV programme putting coinfected patients at risk of liver complications. However, the excellent uptake of HBV screening and linkage to care in our study suggests feasible improvements

    Ammonia Gas Sensing Characteristics of Spin Coated Polyaniline Films

    Get PDF
    The conductive layer of emeraldine base polyaniline (PANI) thin film coated on silicon has successfully tested for ammonia. The bulk PANI powder was synthesized by oxidative polymerization of aniline using ammonium peroxidisulfate in an acidic medium and dissolved in N-methyl pyrrolidone (NMP) for coating the thin film on Silicon using spin coater. FTIR, UVvisible, and SEM were used to characterize the PANI thin film. The electrical conductivity of the PANI films has been studied by measuring the change in electrical conductivity by Four Probe Set up on exposure to ammonia gas (NH3) at different concentrations from 100 ppm to 500 ppm. margin

    Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: Bevacizumab in combination with interferon-α2a compared with sunitinib

    Get PDF
    Background: Bevacizumab plus interferon-α2a (IFN) prolongs progression-free survival to>10 months, which is comparable with sunitinib as first-line treatment of metastatic renal cell carcinoma (RCC). The two regimens have different tolerability profiles; therefore, costs for managing adverse events may be an important factor in selecting therapy.Methods: Costs of managing adverse events affecting patients with metastatic RCC eligible for treatment with bevacizumab plus IFN or sunitinib were evaluated using a linear decision analytical model. Management costs were calculated from the published incidence of adverse events and health-care costs for treating adverse events in the United Kingdom, Germany, France and Italy.Results: Adverse event management costs were higher for sunitinib than for bevacizumab plus IFN. The average cost per patient for the management of grade 3-4 adverse events was markedly lower with bevacizumab plus IFN compared with sunitinib in the United Kingdom (\[euro]1475 vs \[euro]804), Germany (\[euro]1785 vs \[euro]1367), France (\[euro]2590 vs \[euro]1618) and Italy (\[euro]891 vs \[euro]402). The main cost drivers were lymphopaenia, neutropaenia, thrombocytopaenia, leucopaenia and fatigue/asthaenia for sunitinib; and proteinuria, fatigue/asthaenia, bleeding, anaemia and gastrointestinal perforation for bevacizumab plus IFN.Conclusion: The costs of managing adverse events are lower for bevacizumab plus IFN than for sunitinib. The potential for cost savings should be considered when selecting treatments for RCC

    Evaluation of Ferrocene Derivatives as Burn Rate Modifiers in AP/HTPB-Based Composite Propellants

    Get PDF
    Some ferrocene derivatives like 2,4-dinitrophenylhydrazine derivative of acetyl ferrocene, 1-pyrrolidinylmethyl ferrocene, di-ter-butyl ferrocene and 1,3-diferrocenyl-l-butene (DFB) have been synthesised and characterised by infrared, nuclear magnetic resonance, ultraviolet, iron content, etc. To study the effect of their incorporation on performance, ammonium perchlorate/hydroxyl-terminated polybutadiene-based composite propellants containing these derivatives have been prepared and studied for burn rates, tensile strength and percentage elongation followed by their static test evaluation. A comparison of the properties of propellant containing solid and liquid ferrocene derivatives has been made with those containing Fe/sub 2/O/sub 3/ and n-butyl ferrocene, respectively. The data clearly indicates that these ferrocene derivatives are better than Fe/sub 2/O/sub 3/ and n-butyl errocene. Also, DFB is the best among these derivatives. Like composite propellants, DFB increases burn rate in fuel-rich propellants also
    • 

    corecore